[Tafamidis (wild-type or hereditary transthyretin amyloid cardiomyopathy) - Assessment according to §35a (para. 1., sentence 11) Social Code Book V]
Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen
Record ID 32018003686
German
Original Title:
Tafamidis (Wildtyp- oder hereditaere Transthyretin-Amyloidose mit Kardiomyopathie)
Details
Project Status:
Completed
URL for project:
https://www.iqwig.de/projekte/g20-03.html
Year Published:
2020
URL for published report:
https://www.iqwig.de/download/G20-03_Tafamidis_Bewertung-35a-Absatz-1-Satz-11-SGB-V_V1-0.pdf
English language abstract:
There is no English language summary available
Publication Type:
Full HTA
Country:
Germany
MeSH Terms
- Benzoxazoles
- Amyloid Neuropathies, Familial
- Cardiomyopathies
- Heart Failure
Keywords
- Tafamidis
- Amyloid Neuropathies - Familial
- Health Care Costs
- Epidemiology
Contact
Organisation Name:
Institute for Quality and Efficiency in Health Care (IQWiG)
Contact Address:
IQWiG, Siegburger Str. 237, 50679 Cologne, GERMANY, Tel: +49(0)221-35685, Fax: +49(0)221-356851
Contact Email:
berichte@iqwig.de
Copyright:
Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.